Open Access
- 30 January 2025
- journal article
- Published by Elsevier in JHEP Reports
- Vol. 7 (5) , 101336
Abstract
No abstract availableKeywords
Funding Information
- Fundación Científica Asociación Española Contra el Cáncer (PRYCO234831)
- European Commission (PI22/01427, PI18/0358)
- Instituto de Salud Carlos III (PI21/00714, PI18/00961)
- Center for International Business Education and Research, University of Illinois at Urbana-Champaign (S2300092_3)
- Centro de Investigación Biomédica en Red de Cáncer
- Asociación Española para el Estudio del Hígado
This publication has 34 references indexed in Scilit:
- 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2022
- Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United StatesHepatology Communications, 2022
- Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancerCell Metabolism, 2022
- Consenso AEEH «Consenso sobre métodos de detección y derivación de enfermedades hepáticas prevalentes ocultas»Gastroenterología y Hepatología, 2022
- The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?Journal of Hepatology, 2022
- Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta‐AnalysisHepatology, 2020
- Risk of Cirrhosis and Hepatocellular Cancer in Patients With NAFLD and Normal Liver EnzymesHepatology, 2020
- Long‐Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral AgentsHepatology, 2019
- Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary teamJournal of Hepatology, 2014
- Randomized controlled trial of screening for hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2004